These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32410883)

  • 1. Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression.
    Wang Y; Wang H; Ruan J; Zheng W; Yang Z; Pan W
    Cancer Cell Int; 2020; 20():155. PubMed ID: 32410883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p.
    Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L
    J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p.
    Yu Q; Li Y; Peng S; Li J; Qin X
    Open Med (Wars); 2021; 16(1):512-525. PubMed ID: 33821219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.
    Liu Y; Cai X; Cai Y; Chang Y
    J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA OIP5-AS1 Knockdown Enhances CDDP Sensitivity in Osteosarcoma via miR-377-3p/FOSL2 Axis.
    Liu L; Wang S
    Onco Targets Ther; 2020; 13():3853-3866. PubMed ID: 32440152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis.
    Zhi XH; Jiang K; Ma YY; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted Article: LncRNA OIP5-AS1 contributes to ox-LDL-induced inflammation and oxidative stress through regulating the miR-128-3p/CDKN2A axis in macrophages.
    Li X; Cao Q; Wang Y; Wang Y
    RSC Adv; 2019 Dec; 9(71):41709-41719. PubMed ID: 35541591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway.
    Meng X; Ma J; Wang B; Wu X; Liu Z
    J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
    Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA OIP5-AS1 promotes the proliferation and migration of vascular smooth muscle cells via regulating miR-141-3p/HMGB1 pathway.
    Dong H; Jiang G; Zhang J; Kang Y
    Am J Med Sci; 2022 Jun; 363(6):538-547. PubMed ID: 35278365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p/TRIM14 axis.
    Xiao Z; Li J; Jin Q; Liu D
    Exp Ther Med; 2021 Apr; 21(4):408. PubMed ID: 33692839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
    Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
    J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of LncRNA OIP5-AS1 Induced by IL-1β Aggravates Osteoarthritis via Regulating miR-29b-3p/PGRN.
    Zhi L; Zhao J; Zhao H; Qing Z; Liu H; Ma J
    Cartilage; 2021 Dec; 13(2_suppl):1345S-1355S. PubMed ID: 32037864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of lncRNA OIP5-AS1 Attenuates Apoptosis and Inflammation, and Promotes Proliferation by Mediating miR-25-3p Expression in Lipopolysaccharide-Induced Myocardial Injury.
    Ma J; Qian H; Zou H
    Anal Cell Pathol (Amst); 2023; 2023():3154223. PubMed ID: 36994450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p.
    Wang M; Sun X; Yang Y; Jiao W
    Thorac Cancer; 2018 Aug; 9(8):939-949. PubMed ID: 29897167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis.
    Zheng Z; Zhang G; Liang X; Li T
    Mol Cell Biochem; 2021 Jan; 476(1):443-455. PubMed ID: 32990894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA OIP5-AS1 Targets the miR-140-5p/UBR5 Cascade to Promote the Development of Gastric Cancer.
    Liu M; Song X; Sun Y; Zhang T
    Mol Biotechnol; 2023 Dec; ():. PubMed ID: 38112962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
    Liang J; Tian XF; Yang W
    World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of OIP5-AS1 Protects Endothelial Cells From ox-LDL-Triggered Injury by Regulating KLF5 Expression via Sponging miR-135a-5p.
    Zhao M; Yang Y; Li J; Lu M; Wu Y
    Front Cardiovasc Med; 2021; 8():596506. PubMed ID: 33778018
    [No Abstract]   [Full Text] [Related]  

  • 20. Long Non-Coding RNA OIP5-AS1 Contributes to Gallbladder Cancer Cell Invasion and Migration by miR-143-3p Suppression.
    Li J; Zhang H; Luo H
    Cancer Manag Res; 2020; 12():12983-12992. PubMed ID: 33364844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.